ATE316375T1 - Orale feste zusammensetzung - Google Patents

Orale feste zusammensetzung

Info

Publication number
ATE316375T1
ATE316375T1 AT00974881T AT00974881T ATE316375T1 AT E316375 T1 ATE316375 T1 AT E316375T1 AT 00974881 T AT00974881 T AT 00974881T AT 00974881 T AT00974881 T AT 00974881T AT E316375 T1 ATE316375 T1 AT E316375T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
krp
quantitatively
oral solid
additives
Prior art date
Application number
AT00974881T
Other languages
English (en)
Inventor
Toshinori Ohyama
Masahiko Ohishi
Yasuhiro Yamamoto
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE316375T1 publication Critical patent/ATE316375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00974881T 1999-11-11 2000-11-10 Orale feste zusammensetzung ATE316375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32058599 1999-11-11

Publications (1)

Publication Number Publication Date
ATE316375T1 true ATE316375T1 (de) 2006-02-15

Family

ID=18123071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974881T ATE316375T1 (de) 1999-11-11 2000-11-10 Orale feste zusammensetzung

Country Status (12)

Country Link
US (1) US7351429B1 (de)
EP (1) EP1245232B1 (de)
JP (1) JP4610834B2 (de)
AT (1) ATE316375T1 (de)
AU (1) AU1304501A (de)
CA (1) CA2390933C (de)
CY (1) CY1104982T1 (de)
DE (1) DE60025750T2 (de)
DK (1) DK1245232T3 (de)
ES (1) ES2254246T3 (de)
TW (1) TWI221412B (de)
WO (1) WO2001034147A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060188554A1 (en) * 2003-08-04 2006-08-24 Katashi Nakashima Transdermal absorption preparation
WO2005011682A1 (ja) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. 経口徐放性錠剤
US20080107727A1 (en) * 2005-01-31 2008-05-08 Katashi Nakashima Multiple Unit Oral Sustained Release Preparation and Production Method Thereof
KR101312814B1 (ko) 2005-02-03 2013-09-27 오노 야꾸힝 고교 가부시키가이샤 경피 흡수형 제제
CN101983054B (zh) * 2008-01-31 2013-08-14 杏林制药株式会社 含有咪达那新的口腔内迅速崩解性片剂
DK2246051T3 (da) 2008-01-31 2014-01-13 Kyorin Seiyaku Kk Fremgangsmåde til fremstilling af oralt sig hurtigt opløsende tablet omfattende imidafenacin som aktiv bestanddel
JP5452050B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシンを含有する口腔内崩壊錠
JP5452051B2 (ja) * 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシン含有口腔内崩壊錠
JP5713544B2 (ja) * 2009-07-30 2015-05-07 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP5844573B2 (ja) * 2011-08-10 2016-01-20 共和薬品工業株式会社 ピタバスタチンを含有する錠剤
JP5757493B1 (ja) * 2014-09-24 2015-07-29 富田製薬株式会社 経口型鉄分補給用固形組成物及びその製造方法
JP6127295B2 (ja) * 2015-03-10 2017-05-17 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6630344B2 (ja) * 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
WO2016148263A1 (ja) 2015-03-19 2016-09-22 第一三共株式会社 抗酸化剤を含有する固形製剤
JP6072884B2 (ja) * 2015-11-19 2017-02-01 共和薬品工業株式会社 ピタバスタチンを含有する製剤
WO2017110965A1 (ja) 2015-12-25 2017-06-29 杏林製薬株式会社 バソプレシン様作用増強剤
JP6212588B2 (ja) * 2016-03-24 2017-10-11 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
WO2017162852A1 (en) * 2016-03-25 2017-09-28 Universiteit Gent Oral dosage form
US10966928B2 (en) * 2016-03-25 2021-04-06 Universiteit Gent Oral dosage form
JP6303037B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6303038B2 (ja) * 2017-02-14 2018-03-28 杏林製薬株式会社 イミダフェナシン含有口腔内速崩錠
JP6423035B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有造粒物のコーティング顆粒
JP6423034B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 イミダフェナシン含有錠剤
JP6435362B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤
JP6303045B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 攪拌造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP6509934B2 (ja) * 2017-03-30 2019-05-08 杏林製薬株式会社 直打法によるイミダフェナシンを含有する錠剤の製造方法
JP6303044B1 (ja) * 2017-03-30 2018-03-28 杏林製薬株式会社 押出し造粒法を用いたイミダフェナシンを含有する製剤の製造方法
JP6423033B2 (ja) * 2017-03-30 2018-11-14 杏林製薬株式会社 製造工程分解物の少ないイミダフェナシンを含有する造粒物
JP6435363B2 (ja) * 2017-03-30 2018-12-05 杏林製薬株式会社 湿式造粒法によるイミダフェナシンを含有する造粒物の製造方法
JP7365157B2 (ja) 2018-07-17 2023-10-19 沢井製薬株式会社 イミダフェナシン含有錠剤の製造方法
JP2019019148A (ja) * 2018-11-12 2019-02-07 杏林製薬株式会社 保存安定性に優れたイミダフェナシンを含有する製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206533A (ja) 1982-05-27 1983-12-01 Teijin Ltd 活性型ビタミンｄ↓３誘導体組成物及びそれを活性成分とする薬剤
US4797405A (en) * 1987-10-26 1989-01-10 Eli Lilly And Company Stabilized pergolide compositions
US5084278A (en) 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
JP3294961B2 (ja) * 1993-12-10 2002-06-24 杏林製薬株式会社 新規イミダゾール誘導体及びその製造法
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
EP0901787B1 (de) 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Stabilisierte pharmazeutische Zusammensetzung
JP3901832B2 (ja) 1998-03-13 2007-04-04 大日本インキ化学工業株式会社 キノリノン誘導体製剤、及びその製造法

Also Published As

Publication number Publication date
CY1104982T1 (el) 2009-11-04
AU1304501A (en) 2001-06-06
US7351429B1 (en) 2008-04-01
DK1245232T3 (da) 2006-03-06
DE60025750D1 (de) 2006-04-13
EP1245232A4 (de) 2004-05-06
ES2254246T3 (es) 2006-06-16
WO2001034147A1 (fr) 2001-05-17
EP1245232A1 (de) 2002-10-02
TWI221412B (en) 2004-10-01
CA2390933A1 (en) 2001-05-17
DE60025750T2 (de) 2006-10-19
EP1245232B1 (de) 2006-01-25
JP4610834B2 (ja) 2011-01-12
CA2390933C (en) 2009-07-14

Similar Documents

Publication Publication Date Title
ATE316375T1 (de) Orale feste zusammensetzung
NO20020180D0 (no) Nye kinuklidinderivater og medisinske sammensetninger inneholdende det samme
DE69206345T2 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
DK1161248T3 (da) Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger
ES2051782T3 (es) Una composicion farmaceutica de liberacion lenta.
DK1205190T3 (da) Stabile medicinalsammensætninger til oral administration og med anvendelse af ferrioxider
DE3686483T2 (de) Arzneimittel.
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
EA200200812A1 (ru) Фармацевтическая композиция, содержащая низкую дозу энтекавира, и ее применение
BR0312563A (pt) Comprimido de lasofoxifeno e seu revestimento
NZ514248A (en) Pharmaceutical composition in a unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
ATE87481T1 (de) Orale arzneimittelformen von pimobendan.
ES2034926T1 (es) Composiciones farmaceuticas orales liquidas con actividad anti-inflamatoria.
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
DE69228674D1 (de) Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
DE69521924T2 (de) Pharmazeutische Darreichungsformen mit verzögerter Wirkstoffabgabe enthaltend Alfuzosinhydrochlorid
GB9814215D0 (en) Anti-inflammatory pharmaceutical formulations
ATE129891T1 (de) Ein ibuprofen enthaltendes retard-arzneimittel und seine verwendung.
DE59205626D1 (de) Ein flurbiprofen enthaltendes retard-arzneimittel und seine verwendung
IE811773L (en) Pharmaceutical comosition containing imidazolesalicylate
GB950065A (en) Pharmaceutical preparations comprising 1:3-benzoxazine-2:4-dione
ES381115A1 (es) Un metodo de preparacion de 1,1'-metilen-bis - (4-(3-cloro-fenil) piperazina).

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1245232

Country of ref document: EP